Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
94 /100
COMPONENT-LIMITED
Score updated Aug 18, 2026

INDP — Indaptus Therapeutics, Inc. Dilution Risk Tracker

Track INDP dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track INDP — Get alerts when the score changes →

As of August 18, 2026, Indaptus Therapeutics, Inc. (INDP) has a DilutionWatch DilutionScore of 94/100, rated CRITICAL dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Indaptus Therapeutics, Inc. has a market capitalization of $199.31M, 133.24M shares outstanding, 1 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
85
📊 Float Risk
100
⚠️ Warrant Exposure
40
🔄 Convertible Debt
85

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 49%
🔁 Convertible Conversion model 60%
• Major convertible overhang: 83% potential dilution
• Convertible risk score very high (85/100)
📉 Score Deterioration model 40%
• Score increased 10 points recently (worsening)
• Score already CRITICAL (94/100) — events likely imminent
💰 Capital Raise model 35%
• Low cash runway: 5 months remaining
🔔 Track INDP — Get forecast alerts →

Market Data

Market Cap$199.31M
Shares Outstanding133.24M
Float3.24M
Cash$11.55M
DebtN/A
Short InterestN/A

Institutional Holdings

QoQ: ↓ 100.0% shares (2026Q1 vs prior)
1 institutional holders · 2 shares
#1 DANSKE BANK A/S 2 shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest93.1K
Days to Cover1.1
% of Float2.9%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-31
xbrl XBRL CONVERTIBLE 2025-12-31
3 FORM3 2026-04-20
3 FORM3 2026-04-02
3 FORM3 2026-04-02
Full SEC filing analysis available with free account

Recent News

No recent news

Factual INDP Dilution Snapshot

Indaptus Therapeutics, Inc. (INDP) has a DilutionScore of 94/100, rated Critical dilution risk. Score date: August 18, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track INDP Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking INDP — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

More Research for INDP
INDP FDA Catalyst Timeline & Biotech Grade — BiotechSigns📄 INDP Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.